Amferia kills bacteria

Amferia is excited to announce that we will be attending and exhibiting at the upcoming Vet Shows in New York and London in November. 🚀 We're looking forward to connecting with animal health companies to explore partnership opportunities and introduce our innovative wound dressing for advanced animal wound care. 🐾 We’re also eager to meet as many #veterinarians as possible who have supported our innovation from the start. Your valuable feedback is essential, and we would love for you to test our product firsthand. If you're interested in booking a meeting with us, please feel free to reach out to Saba Atefyekta, our Sales Director. You can also stop by our booth to meet us in person and experience our product. Amferia is proud to be offering new wound care solutions for animals, and our market presence is growing fast! 🌍✨ For more information, visit our website: https://lnkd.in/eYYSngcj We look forward to seeing you at the shows! #WoundCare #AnimalHealth #Amferia #InnovationInAnimalCare #PartnershipOpportunities #LVS2024 #NYVS2024 #veterinarian

Time of the week celebrate a Great Week of Investment as a number of exciting companies announce funding rounds and investments. Why not check out their website and see if they have any suitable jobs in Tech, Product, Sales, Marketing, and HR. Reonic and assetbird in Germany, Root Signals in Finland, Palm in the UK, Steerlab in France, Tiptapp and Amferia kills bacteria in Sweden, Treble Technologies in Iceland, Ventory in Belgium, Involve Space, IdentifAI - Find Origin - and Skillvue in Italy. If we've missed some good news stories across the tech world in Europe this week; let us know! Follow and Credit: Mentor Talent Acquisition EU-Startups Sifted

𝗔𝗺𝗳𝗲𝗿𝗶𝗮 𝗰𝗹𝗼𝘀𝗲𝘀 €𝟭,𝟮 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝘁𝗼 𝗰𝗼𝗺𝗯𝗮𝘁 𝗿𝗲𝘀𝗶𝘀𝘁𝗮𝗻𝘁 𝗯𝗮𝗰𝘁𝗲𝗿𝗶𝗮𝗹 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻𝘀: Amferia, a Swedish medtech company focused on developing innovative antimicrobial healthcare solutions, announces the successful closure of a 1.2-million-euro investment round. The round was over prescribed and spearheaded by existing owners and new investors. The funding will support the advancement of clinical development within Human Health and further the commercialization of Amferia’s pipeline built on its proprietary platform, designed to protect and utilize antimicrobial peptides to combat bacterial infections. Amferia has already entered the animal health segment and signed commercial agreements with leading animal health companies in Europe such as Orkla Wound Care AB and Biokema SA, to introduce a wound dressing that also kills resistant bacteria. #startup 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: https://lnkd.in/e4wJX2au Amferia kills bacteria, Anand Kumar Rajasekharan

Time of the week celebrate a Great Week of Investment as a number of exciting companies announce funding rounds and investments. Why not check out their website and see if they have any suitable jobs in Tech, Product, Sales, Marketing, and HR. Reonic and assetbird in Germany, Root Signals in Finland, Palm in the UK, Steerlab in France, Tiptapp and Amferia kills bacteria in Sweden, Treble Technologies in Iceland, Ventory in Belgium, Involve Space, IdentifAI - Find Origin - and Skillvue in Italy. If we've missed some good news stories across the tech world in Europe this week; let us know! Follow and Credit: Mentor Talent Acquisition EU-Startups Sifted

BeBeez International reports that Amferia kills bacteria, a Swedish medtech company specializing in antimicrobial solutions to combat bacterial resistance, has secured €1.2 million in an oversubscribed round led by Chalmers Ventures. CEO Anand Kumar Rajasekharan and Chairman Agneta Edberg highlight how this funding will accelerate the development of Amferia’s innovative hydrogel platform for treatment resistant bacteria in human health. With existing applications in animal care, this investment aims at obtaining the necessary regulatory approvals for human use, marking a significant step in the fight against antibiotic-resistant infections. https://lnkd.in/dEbmKXTR #HealthTech

İsveç merkezli tıbbi teknoloji şirketi Amferia kills bacteria, antimikrobiyal dirençle mücadele amacıyla geliştirdiği yenilikçi hidrojel teknolojisini ilerletmek için €1.2 milyon yatırım aldı. Bu yatırım turuna Chalmers Ventures gibi mevcut yatırımcılar katıldı ve Amferia'nın klinik geliştirme süreçlerini hızlandırması hedefleniyor. Haberin detayları 👉 https://lnkd.in/dyfVGQEe

The Amferia team is happy to announce the successful closing our recent #investment round. A big thank you to our existing owners for your continued support as well as welcoming our new investors. We look forward to continue building Amferia kills bacteria to greater heights together! https://lnkd.in/djPRMZ6d Saba Atefyekta, Edvin Blomstrand, Rojan Modaresi, Daniel Hagberg, My Nyblom, PhD, Maya Awada, Ulrika Ågren, Jonas Bergman, Björn Engström, Alexandra De Wever Treschow, Ingvar Karlsson, Parvin Zamani

#fundingalert 💼Company: Amferia kills bacteria 💰Funding: €1.2Million ⚡Round: New Round 👥Investors: Chalmers Ventures, the investment arm of Chalmers University of Technology in Gothenburg, along with other new investors. Swedish business Amferia AB creates and distributes innovative medical equipment, specializing in antibacterial goods. Amferia's main goal is to create materials that, when utilized as medical devices—such as wound care—can effectively destroy bacteria. Amferia is a spin-off from Chalmers University of Technology research. Jonas Bergman, Anand Kumar Rajasekharan, Saba Atefyekta Read more - https://lnkd.in/eZXdsBFZ To share your startup story write us on - contact@startuprise.co.uk #Amferia #antibacterial #Technology #research #Funding #news #startup #fundraising

Mölndal-based Amferia kills bacteria, a Swedish medtech, closed a €1,2 million investment round spearheaded by existing owners and a few new investors, including Chalmers Ventures 🇸🇪 🔬 “Bacterial infections are likely to surpass cancer and heart disease as a number one cause of human deaths in the future, and this is largely due to resistance to commonly used antibiotics,” said Anand Kumar Rajasekharan, CEO and co-founder of Amferia. 

🇸🇪🦠 Swedish #medtech company Amferia kills bacteria raises €1.2M to advance its innovative hydrogel technology designed to fight antimicrobial resistance. 📈 The €1.2M investment round was spearheaded by both existing owners and new investors, including Chalmers Ventures, an investment arm of Chalmers University of Technology in Gothenburg, Sweden. It supports startups and spin-offs emerging from the university’s research, students, and alumni. 🤖 Read more here: https://lnkd.in/epRghjTw Anand Kumar Rajasekharan Jonas Bergman #tech #funding #news #technology #VC #innovation #investment